Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components

NCT02305732 is registered in ClinicalTrials.gov with Cerus Corporation as lead sponsor.

NCT NCT02305732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02305732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components
Lead sponsor
Cerus Corporation
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
May 31, 2016
Enrollment
90 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus, dengue virus